Roszkowski JJ - Search Results

1

Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Nishimura MI, et al. Among authors: roszkowski jj. Cancer Treat Res. 2005;123:37-59. doi: 10.1007/0-387-27545-2_2. Cancer Treat Res. 2005. PMID: 16211865 Review.

2

CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell.

Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI. Roszkowski JJ, et al. J Immunol. 2003 Mar 1;170(5):2582-9. doi: 10.4049/jimmunol.170.5.2582. J Immunol. 2003. PMID: 12594285

3

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

Roszkowski JJ, Lyons GE, Kast WM, Yee C, Van Besien K, Nishimura MI. Roszkowski JJ, et al. Cancer Res. 2005 Feb 15;65(4):1570-6. doi: 10.1158/0008-5472.CAN-04-2076. Cancer Res. 2005. PMID: 15735047

4

T cell avidity and tumor recognition: implications and therapeutic strategies.

McKee MD, Roszkowski JJ, Nishimura MI. McKee MD, et al. Among authors: roszkowski jj. J Transl Med. 2005 Sep 20;3:35. doi: 10.1186/1479-5876-3-35. J Transl Med. 2005. PMID: 16174302 Free PMC article.

5

T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells.

Lyons GE, Roszkowski JJ, Man S, Yee C, Kast WM, Nishimura MI. Lyons GE, et al. Among authors: roszkowski jj. Cancer Immunol Immunother. 2006 Sep;55(9):1142-50. doi: 10.1007/s00262-005-0103-9. Epub 2005 Dec 23. Cancer Immunol Immunother. 2006. PMID: 16374636 Free PMC article.

6

Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Callender GG, et al. Among authors: roszkowski jj. Hepatology. 2006 May;43(5):973-81. doi: 10.1002/hep.21157. Hepatology. 2006. PMID: 16628627

7

Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.

Lyons GE, Moore T, Brasic N, Li M, Roszkowski JJ, Nishimura MI. Lyons GE, et al. Among authors: roszkowski jj. Cancer Res. 2006 Dec 1;66(23):11455-61. doi: 10.1158/0008-5472.CAN-06-2379. Cancer Res. 2006. PMID: 17145893

8

Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

Moore TV, Lyons GE, Brasic N, Roszkowski JJ, Voelkl S, Mackensen A, Kast WM, Le Poole IC, Nishimura MI. Moore TV, et al. Among authors: roszkowski jj. Cancer Immunol Immunother. 2009 May;58(5):719-28. doi: 10.1007/s00262-008-0594-2. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836717 Free PMC article.

9

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.

Norell H, Zhang Y, McCracken J, Martins da Palma T, Lesher A, Liu Y, Roszkowski JJ, Temple A, Callender GG, Clay T, Orentas R, Guevara-Patiño J, Nishimura MI. Norell H, et al. Among authors: roszkowski jj. Cancer Immunol Immunother. 2010 Jun;59(6):851-62. doi: 10.1007/s00262-009-0810-8. Epub 2010 Jan 6. Cancer Immunol Immunother. 2010. PMID: 20052466 Free PMC article.

10

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.

Spear TT, Callender GG, Roszkowski JJ, Moxley KM, Simms PE, Foley KC, Murray DC, Scurti GM, Li M, Thomas JT, Langerman A, Garrett-Mayer E, Zhang Y, Nishimura MI. Spear TT, et al. Among authors: roszkowski jj. Cancer Immunol Immunother. 2016 Mar;65(3):293-304. doi: 10.1007/s00262-016-1800-2. Epub 2016 Feb 3. Cancer Immunol Immunother. 2016. PMID: 26842125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page